Drawing for THERMO FISHER

USPTO serial 86695101

THERMO FISHER

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
YOUNG, THOMAS PAUL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THERMO FISHER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alan M. Doernberg

300 Industry DrPittsburgh, PA 15275-1001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Advertising and promotional services related to scientific, electrical, optical, measuring, laboratory, and test apparatus and instruments and computer hardware and software used in connection therewith; Retail store services and online retail store services featuring scientific, electrical, optical, measuring, laboratory, and test apparatus and instruments; Advertising services, namely, promoting the electronic storage services of others for data, graphs, images and information in the fields of cloud computing, life science, medical research, scientific research and clinical research; Providing business intelligence services in the field of life sciencesACTIVE—
042Providing an on-line computer database featuring scientific and medical research information in the field of genetics; Research in the fields of science, technology, medicine and health, namely, nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Consultation services in the field of science and technology consultation in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Consulting services in the field of cloud computing in the fields of life science; Consulting services in the fields of bioinformatics, namely, the development of software for understanding biological data; Computer services, namely, providing temporary use of on-line non-downloadable software for accessing and analyzing information in the field of science, technology, medicine, health and public policy; providing online non-downloadable software for the custom design and ordering of assays and reagents; Medical research and laboratory diagnostic services in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Product development for others; Laboratory services, namely, nucleic acid sequencing, synthesis and analysis, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Laboratory services, namely, nucleic acid analysis; Scientific research in the field of genetics, namely, gene discovery; Scientific research in the field of genetics, namely, genetic diseases, genomics and gene expression research and development; Research on the subject of pharmaceuticals, namely, pharmacokinetics; Scientific research services in the field of proteomics; Genetic testing and mapping services for scientific purposes, namely, gene identification, gene cloning, gene expression, electrophoresis, protein purification and analysis, and protein interaction detection; Medical and scientific research; Medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; Technical research and consultation related thereto in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; Pharmaceutical research services; Providing an on-line searchable database in the field of life science for scientific research purposes; Providing medical and scientific research information in the fields of pharmaceuticals, molecular diagnostics, and genetics; Development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; Medical laboratory services; Research and development for new immunotherapy products for others; Scientific research services; Medical laboratory testing and diagnostic services for others in the fields of science and research related thereto; Scientific research, namely, developing customized microbiological, mammalian, and insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; Contract medical laboratory services, namely, conducting drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, namely, enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and p-glycloprotein assays; Consulting services in the field of contract medical laboratory services, namely, conducting drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, namely, enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and p-glycloprotein assays; Electronic storage of data, graphs, images and information in the fields of cloud computing, life science, medical research, scientific research and clinical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 19, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 19, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 21, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 20, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 19, 2018EX5GSOU EXTENSION 5 GRANTED—
Jul 19, 2018EXT5SOU EXTENSION 5 FILED—
Jul 19, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 18, 2018EX4GSOU EXTENSION 4 GRANTED—
Jul 18, 2018EXT4SOU EXTENSION 4 FILED—
Jul 18, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 20, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2018EX3GSOU EXTENSION 3 GRANTED—
Jan 18, 2018EXT3SOU EXTENSION 3 FILED—
Jan 18, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 21, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 19, 2017EX2GSOU EXTENSION 2 GRANTED—
Jul 19, 2017EXT2SOU EXTENSION 2 FILED—
Jul 19, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 13, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 11, 2017EX1GSOU EXTENSION 1 GRANTED—
Jan 11, 2017EXT1SOU EXTENSION 1 FILED—
Jan 11, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 19, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 24, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 24, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 4, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 19, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Apr 18, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 18, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 18, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 15, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 15, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 15, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2015DOCKASSIGNED TO EXAMINER—
Jul 22, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 20, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance